The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Orlando, Fla. – The American Society of Clinical Oncology (ASCO) today announced the Quality Oncology Practice Initiative (QOPI®) Certification Program, a new program to certify oncology practices that achieve rigorous standards for high-quality cancer care.
Orlando, Fla.— The findings from several large studies on lung cancer were released today at a press briefing at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Alexandria, VA— Approximately 30,000 cancer specialists from around the world are expected to gather at the end of May in Orlando, FL, for the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), to discuss the latest advances in cancer care, treatment, prevention and survivorship.
Alexandria, Va.—The ASCO Cancer Foundation will award more than $6.1 million to support clinical and translational research designed to improve cancer prevention, treatment and care. The grants will be awarded to 63 researchers at the American Society of Clinical Oncology’s 45th Annual Meeting in Orlando, May 29 – June 2.
ALEXANDRIA, Va. —The American Society of Clinical Oncology (ASCO) awarded $10,000 grants to five of its State and Regional Affiliates to fund projects that address the varying needs of oncologists and people with cancer in their communities.
Chicago, IL—Two plenary studies and other research evaluating screening and treatment options for patients with lung and testicular cancer were released today at a press briefing for the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Chicago, IL—New studies in the field of pharmacogenomics pinpoint molecular characteristics that may explain how patients respond to cancer drugs, and identify new molecular diagnostic tools for cancer. The studies were released today at a press briefing at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Chicago, IL—New studies evaluating the latest treatments and quality-of-life improvements for cancer patients were presented today at a press briefing of the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Chicago, IL— Plenary and late-breaking studies that advance the treatment of both early and advanced breast cancer were released today at a press briefing at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Alexandria, VA—The ASCO Cancer Foundation will honor over 100 oncologists and oncology fellows with the International Development and Education Award (IDEA) and Merit Awards at the the American Society of Clinical Oncology’s 44th Annual Meeting in Chicago.
